Hongbo Du
- Hepatology top 10%
- Liver Disease and Transplantation 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Drug-Induced Hepatotoxicity and Protection 2
-
- Liver Disease Diagnosis and Treatment 13
- Hepatitis B Virus Studies 3
-
- Diet, Metabolism, and Disease 2
In The Last Decade
Hongbo Du
23 papers receiving 339 citations
Peers
Comparison fields: 5 of 83
- Hepatology 84
- Cancer Research 87
- Gastroenterology 17
- Pharmacology 23
- Epidemiology 88
Countries citing papers authored by Hongbo Du
This map shows the geographic impact of Hongbo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Du more than expected).
Fields of papers citing papers by Hongbo Du
This network shows the impact of papers produced by Hongbo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Du. The network helps show where Hongbo Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbo Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 150 | |
| 16 | 2020 | 8 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 1 | |
| 19 | 2017 | 20 | |
| 20 | 2017 | 13 |
About Hongbo Du
Hongbo Du is a scholar working on Hepatology, Pharmacology and Cancer Research, having authored 27 papers that have together received 342 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (4 papers), Cancer, Lipids, and Metabolism (3 papers), Hepatitis B Virus Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Diet, Metabolism, and Disease (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Hepatology (84 citations), Cancer Research (87 citations) and Gastroenterology (17 citations). Hongbo Du has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Yongan Ye, Danan Gan, Xiaoke Li, Jiaying Zhang, Jiaxin Zhang, Xu Cao, Mei Han, Guang Chen, Peng Zhang and Ludan Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.